Long‐term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial.

MLA

Pompili, Enrico, et al. “Long‐term Albumin Improves the Outcomes of Patients with Decompensated Cirrhosis and Diabetes Mellitus: Post Hoc Analysis of the ANSWER Trial.” Liver International, vol. 44, no. 9, Sept. 2024, pp. 2108–13. EBSCOhost, https://doi.org/10.1111/liv.16020.

APA

Pompili, E., Baldassarre, M., Iannone, G., Tedesco, G., Nardelli, S., Piano, S., Alessandria, C., Neri, S., Foschi, F. G., Levantesi, F., Caraceni, P., Bernardi, M., Zaccherini, G., Domenicali, M., Giannone, F. A., Antognoli, A., Riggio, O., Merli, M., Pasquale, C., & Gioia, S. (2024). Long‐term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial. Liver International, 44(9), 2108–2113. https://doi.org/10.1111/liv.16020

Chicago

Pompili, Enrico, Maurizio Baldassarre, Giulia Iannone, Greta Tedesco, Silvia Nardelli, Salvatore Piano, Carlo Alessandria, et al. 2024. “Long‐term Albumin Improves the Outcomes of Patients with Decompensated Cirrhosis and Diabetes Mellitus: Post Hoc Analysis of the ANSWER Trial.” Liver International 44 (9): 2108–13. doi:10.1111/liv.16020.